These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation. Garcia RF; Morales E; Garcia CE; Saksena S; Hübscher SG; Elias E Arq Gastroenterol; 2001; 38(4):247-53. PubMed ID: 12068535 [TBL] [Abstract][Full Text] [Related]
33. Experimental non-alcoholic steatohepatitis in Göttingen Minipigs: consequences of high fat-fructose-cholesterol diet and diabetes. Schumacher-Petersen C; Christoffersen BØ; Kirk RK; Ludvigsen TP; Zois NE; Pedersen HD; Vyberg M; Olsen LH J Transl Med; 2019 Apr; 17(1):110. PubMed ID: 30943987 [TBL] [Abstract][Full Text] [Related]
34. The Role of Multiparametric US of the Liver for the Evaluation of Nonalcoholic Steatohepatitis. Sugimoto K; Moriyasu F; Oshiro H; Takeuchi H; Abe M; Yoshimasu Y; Kasai Y; Sakamaki K; Hara T; Itoi T Radiology; 2020 Sep; 296(3):532-540. PubMed ID: 32573385 [TBL] [Abstract][Full Text] [Related]
35. Macrosteatotic Allografts and Obese Recipients Have Nearly Equal Negative Impact on Liver Transplant Survival. Northup PG; Intagliata NM; Davis JPE; Argo CK; Pelletier SJ Transplantation; 2020 Jun; 104(6):1193-1200. PubMed ID: 31577675 [TBL] [Abstract][Full Text] [Related]
36. Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand? Mikolasevic I; Stojsavljevic S; Blazic F; Mijic M; Radic-Kristo D; Juric T; Skenderevic N; Klapan M; Lukic A; Filipec Kanizaj T World J Transplant; 2021 Mar; 11(3):37-53. PubMed ID: 33816145 [TBL] [Abstract][Full Text] [Related]
37. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Brown GT; Kleiner DE Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559 [TBL] [Abstract][Full Text] [Related]
38. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
39. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus: issues of the liver fibrosis diagnostics]. Anisonyan AV; Sandler YG; Khaimenova TY; Keyan VA; Saliev KG; Sbikina ES; Vinnitskaya EV Ter Arkh; 2020 Sep; 92(8):73-78. PubMed ID: 33346465 [TBL] [Abstract][Full Text] [Related]
40. Disruption of hepatic small heterodimer partner induces dissociation of steatosis and inflammation in experimental nonalcoholic steatohepatitis. Magee N; Zou A; Ghosh P; Ahamed F; Delker D; Zhang Y J Biol Chem; 2020 Jan; 295(4):994-1008. PubMed ID: 31831621 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]